RESEARCH PAPER
Figure from article: miR-3615 suppresses...
 
KEYWORDS
TOPICS
ABSTRACT
Introduction and objective:
MicroRNAs (miRNAs) are essential in the modulation of cellular activities. Studies suggest that miR-3615 may possess a tumour-suppressive function in lung adenocarcinoma (LUAD); however, its precise role and molecular mechanisms in LUAD progression remain incompletely understood. The aim of the study is to systematically investigate the biological functions and underlying mechanisms of miR-3615 in LUAD.

Material and methods:
The expression of miR-3615 in LUAD cell lines was quantified by real-time quantitative PCR (RT-qPCR). Subsequently, its functional effects on proliferation, migration, invasion, and apoptosis were evaluated in A549 and H1299 cells using the CCK-8 assay, Transwell assay, and flow cytometry, respectively. Potential target genes of miR-3615 were predicted and functionally annotated using bioinformatics methods. The binding interaction of miR-3615 with the CALML4 gene was demonstrated via a dual-luciferase reporter assay.

Results:
miR-3615 expression was notably downregulated in LUAD cell lines compared with normal cells. Overexpression of miR-3615 inhibited the proliferation, migration, and invasion capabilities of LUAD cells while promoting apoptosis. Integrated bioinformatics analysis involving target prediction and functional enrichment identified CALML4 as a key candidate target gene of miR-3615. CALML4 was confirmed as a direct target of miR-3615. The effects of miR-3615 mimic on LUAD cell proliferation, migration, invasion, and apoptosis were partly attenuated by CALML4 overexpression.

Conclusions:
miR-3615 exerts its functional impact on LUAD cells by directly downregulating CALML4, thereby curbing proliferation, migration, and invasion and promoting apoptosis. The elucidated miR-3615/CALML4 axis advances the theoretical foundation for studying LUAD development.
REFERENCES (25)
1.
Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. http://doi.org/10.3322/caac.21....
 
2.
Richtmann S, Wilkens D, Warth A, et al. FAM83A and FAM83B as Prognostic Biomarkers and Potential New Therapeutic Targets in NSCLC. Cancers (Basel). 2019;11(5). http://doi.org/10.3390/cancers....
 
3.
Sorber L, Zwaenepoel K, Deschoolmeester V, et al. Circulating cell-free nucleic acids and platelets as a liquid biopsy in the provision of personalized therapy for lung cancer patients. Lung Cancer. 2017;107:100–7. http://doi.org/10.1016/j.lungc....
 
4.
Jiang M, Jia K, Wang L, et al. Alterations of DNA damage response pathway: Biomarker and therapeutic strategy for cancer immunotherapy. Acta Pharm Sin B. 2021;11(10):2983–94. http://doi.org/10.1016/j.apsb.....
 
5.
Stepicheva NA, Song JL. Function and regulation of microRNA-31 in development and disease. Mol Reprod Dev. 2016;83(8):654–74. http://doi.org/10.1002/mrd.226....
 
6.
Yuan X, Zhang Y, Yu Z. Expression and clinical significance of miR-3615 in hepatocellular carcinoma. J Int Med Res. 2021;49(1):300060520981547. http://doi.org/10.1177/0300060....
 
7.
Fassan M, Realdon S, Cascione L, et al. Circulating microRNA expression profiling revealed miR-92a-3p as a novel biomarker of Barrett’s carcinogenesis. Pathol Res Pract. 2020;216(5):152907. http://doi.org/10.1016/j.prp.2....
 
8.
Huang G, Liu Y, Li L, et al. Integration analysis of microRNAs as potential biomarkers in early-stage lung adenocarcinoma: the diagnostic and therapeutic significance of miR-183-3p. Front Oncol. 2024;14:1508715. http://doi.org/10.3389/fonc.20....
 
9.
Gao S, Guo W, Liu T, et al. Plasma extracellular vesicle microRNA profiling and the identification of a diagnostic signature for stage I lung adenocarcinoma. Cancer Sci. 2022;113(2):648–59. http://doi.org/10.1111/cas.152....
 
10.
Kim H, Lee YY, Kim VN. The biogenesis and regulation of animal microRNAs. Nat Rev Mol Cell Biol. 2025;26(4):276–96. http://doi.org/10.1038/s41580-....
 
11.
Yang P, Liu J, Yang T, et al. Construction and Investigation of MicroRNA-mRNA Regulatory Network of Gastric Cancer with Helicobacter pylori Infection. Biochem Res Int. 2020;2020:6285987. http://doi.org/10.1155/2020/62....
 
12.
Zhang X, Wen Y, Wu F, et al. GSTA1 Conferred Tolerance to Osimertinib and Provided Strategies to Overcome Drug-Tolerant Persister in EGFR-Mutant Lung Adenocarcinoma. J Thorac Oncol. 2025. http://doi.org/10.1016/j.jtho.....
 
13.
Jiang Y, Zhao L, Wu Y, et al. The Role of NcRNAs to Regulate Immune Checkpoints in Cancer. Front Immunol. 2022;13:853480. http://doi.org/10.3389/fimmu.2....
 
14.
Seijo LM, Peled N, Ajona D, et al. Biomarkers in Lung Cancer Screening: Achievements, Promises, and Challenges. J Thorac Oncol. 2019;14(3):343–57. http://doi.org/10.1016/j.jtho.....
 
15.
Fang G, Zhang C, Liu Z, et al. MiR-144-3p inhibits the proliferation and metastasis of lung cancer A549 cells via targeting HGF. J Cardiothorac Surg. 2022;17(1):117. http://doi.org/10.1186/s13019-....
 
16.
Krętowski R, Jabłońska-Trypuć A, Cechowska-Pasko M. The Effect of Silica Nanoparticles (SiNPs) on Cytotoxicity, Induction of Oxidative Stress and Apoptosis in Breast Cancer Cell Lines. Int J Mol Sci. 2023;24(3). http://doi.org/10.3390/ijms240....
 
17.
Correia de Sousa M, Gjorgjieva M, Dolicka D, et al. Deciphering miRNAs’ Action through miRNA Editing. Int J Mol Sci. 2019;20(24). http://doi.org/10.3390/ijms202....
 
18.
Lukasiewicz M, Zwara A, Kowalski J, et al. The Role of Lipid Metabolism Disorders in the Development of Thyroid Cancer. Int J Mol Sci. 2024;25(13). http://doi.org/10.3390/ijms251....
 
19.
Xu L, Yang Q, Zhou J. Mechanisms of Abnormal Lipid Metabolism in the Pathogenesis of Disease. Int J Mol Sci. 2024;25(15). http://doi.org/10.3390/ijms251....
 
20.
Cheng C, Geng F, Cheng X, Guo D. Lipid metabolism reprogramming and its potential targets in cancer. Cancer Commun (Lond). 2018;38(1):27. http://doi.org/10.1186/s40880-....
 
21.
Tang X, Liu L, Li Y, et al. Chemical profiling and investigation of molecular mechanisms underlying anti-hepatocellular carcinoma activity of extracts from Polygonum perfoliatum L. Biomed Pharmacother. 2023;166:115315. http://doi.org/10.1016/j.bioph....
 
22.
Lin J, Zheng X, Tian X, et al. miR-1247-3p targets STAT5A to inhibit lung adenocarcinoma cell migration and chemotherapy resistance. J Cancer. 2022;13(7):2040–9. http://doi.org/10.7150/jca.651....
 
23.
Tu Y, Mei F. miR-3648 promotes lung adenocarcinoma-genesis by inhibiting SOCS2 (suppressor of cytokine signaling 2). Bioengineered. 2022;13(2):3044–56. http://doi.org/10.1080/2165597....
 
24.
Jiang M, Qi F, Zhang K, et al. MARCKSL1-2 reverses docetaxel-resistance of lung adenocarcinoma cells by recruiting SUZ12 to suppress HDAC1 and elevate miR-200b. Mol Cancer. 2022;21(1):150. http://doi.org/10.1186/s12943-....
 
25.
Chen Y, Zhou Y, Ren R, et al. Harnessing lipid metabolism modulation for improved immunotherapy outcomes in lung adenocarcinoma. J Immunother Cancer. 2024;12(7). http://doi.org/10.1136/jitc-20....
 
eISSN:1898-2263
ISSN:1232-1966
Journals System - logo
Scroll to top